live attenuated mumps vaccine (Jeryl Lynn strain)
Vaccineapproved
Approved
Sep 6, 1966
Clinical trial activity
5 trials · 3 clinical orgs · 1 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01712906)
Timeline
Indications
Approved for
Studied for
Mechanism of action
- Mumps virusImmunity, active
Mumps virus immunity, active
Approval history
- approvedSep 6, 1966
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- attenuated mumps vaccine
- live attenuated mumps vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04591405 | Phase 2/Phase 3 (Phase 3) | Oct 12, 2020 | Chinese Academy of Medical Sciences, Government of China |
| NCT03133923 | Phase 2 | May 1, 2017 | Chinese Academy of Medical Sciences, Government of China |
| NCT05065177 | Phase 3 | Jan 31, 2016 | Government of China, Sinovac Biotech Co., Ltd |
| NCT02692599 | Phase 3 | Jan 1, 2016 | Government of China, Sinovac Biotech Co., Ltd |
| NCT01712906 | Phase 1 | Oct 1, 2012 | Chinese Academy of Medical Sciences, Government of China |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 5 | 0 | 3 | 2012 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 3 | 3 | 2012 |
| Sinovac Biotech Co., Ltd | For profit | 2 | 2 | 1 | 2016 |
3 organizations
Page 1 / 1